Vimarsana
Biggest News Aggregation in the World

Javed Butler News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Javed Butler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Javed Butler Today - Breaking & Trending Today

Study Shows Alarming Rise in Heart Failure Deaths, Especially Among Younger Adults - Vimarsana News

Study Shows Alarming Rise in Heart Failure Deaths, Especially Among Younger Adults

After decades of decline, heart failure mortality is climbing, with a dramatic rise in heart failure deaths among adults age 45 and younger.

Source: duke.edu
Endocrinology Month in Review: April 2024 - Vimarsana News

Endocrinology Month in Review: April 2024

The HCPLive Endocrinology month in review for April 2024 spotlights SURMOUNT-OSA, STEP HFpEF DM, new ACP guidelines for T2D, and more!

ACC: Empagliflozin Does Not Cut Risk for Heart Failure After Acute MI - Vimarsana News

ACC: Empagliflozin Does Not Cut Risk for Heart Failure After Acute MI

No reduction in risk for first hospitalization for heart failure or death seen among patients at increased risk for heart failure

Source: empr.com
Empagliflozin Does Not Cut Risk for Heart Failure After Acute MI - Vimarsana News

Empagliflozin Does Not Cut Risk for Heart Failure After Acute MI

No reduction in risk for first hospitalization for heart failure or death seen among patients at increased risk for heart failure

Study: Empagliflozin shows mixed results in heart attack patients - Vimarsana News

Study: Empagliflozin shows mixed results in heart attack patients

Use of the sodium glucose cotransporter-2 (SGLT-2) inhibitor empagliflozin following a heart attack did not show a significant benefit in reducing overall heart failure hospitalizations or death from any cause, according to a study presented at the American College of Cardiology's Annual Scientific Session.